The present stock price for Prime Medicine Inc (PRME) is $6.52. In the last trading session, the stock made a considerable jump, reaching $7.44 after an opening price of $7.00. The stock briefly fell to $6.49 before ending the session at $7.07.
The market performance of Prime Medicine Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $21.48 on 02/03/23, while the lowest value for the same duration was $5.54 on 10/27/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of PRME Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Prime Medicine Inc’s current trading price is -69.64% away from its 52-week high, while its distance from the 52-week low is 17.69%. The stock’s price range during this period has spanned from $5.54 to $21.48. In the Healthcare sector, the Prime Medicine Inc’s shares surpassed a trading volume of approximately 0.97 million for the day, which was noticeably higher compared to the average daily volume of 9.0.46 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Prime Medicine Inc (PRME) has experienced a quarterly decline of -44.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 634.53M and boasts a workforce of 175 employees.
A Closer Look at Analysts’ Ratings for Prime Medicine Inc
As of right now, 5 analysts are rating Prime Medicine Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.19, with a change in price of -8.12. Similarly, Prime Medicine Inc recorded 396,681 in trading volume during the last 100 days, posting a change of -55.46%.
Examining PRME’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.03.
PRME Stock Stochastic Average
Today, Prime Medicine Inc’s raw stochastic average for the past 50 days stands at 12.67%, indicating a decline from the raw stochastic average of the last 20 days, which was 31.61%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 39.09% and 40.32% respectively.
PRME Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -64.91% this year. Over the last six months, there has been a stronger performance of -49.92%. The price of PRME leaped by -15.32% during the last 30 days period. For the last 5-days stocks have slided -13.07%.
